Director dealings: Poolbeg Pharma co-founder ups stake

(Sharecast News) - Poolbeg Pharma revealed on Monday that chairman Cathal Friel had acquired 830,000 ordinary shares in the AIM-listed biopharmaceutical company. Friel, who co-founded Poolbeg Pharma, purchased the shares at an average price of 11.68p each, for a total value of £96,944.

Following the transaction, Friel holds 37.21m ordinary Poolbeg shares, representing approximately 7.4% of the company's issued share capital.

As of 1620 GMT, Poolbeg shares were up 0.88% at 11.50p.









Reporting by Iain Gilbert at Sharecast.com



Top Director Buys

Poolbeg Pharma (POLB) Director name: Friel,Cathal Amount purchased: 830,000 @ 11.68p Value: £96,944.00

Oryx International Growth Fund Ltd. (OIG) Director name: Mills,Christopher Amount purchased: 6,500 @ 1,147.30p Value: £74,574.50

Oryx International Growth Fund Ltd. (OIG) Director name: Mills,Christopher Amount purchased: 4,500 @ 1,150.00p Value: £51,750.00

Alphawave Ip Group (AWE) Director name: Fonseca,Michelle Senecal de Amount purchased: 25,284 @ 153.40p Value: £38,785.66

(HWG) Director name: Patmore,Katerina Amount purchased: 114 @ 131.89p Value: £150.35

(HWG) Director name: Shillaw,Lynda Amount purchased: 114 @ 131.89p Value: £150.35

(HWG) Director name: Birch,Chris Amount purchased: 114 @ 131.89p Value: £150.35

Xp Factory (XPF) Director name: Harpham,Richard Amount purchased: 939 @ 15.89p Value: £149.21

Xp Factory (XPF) Director name: Bird,Graham Amount purchased: 939 @ 15.89p Value: £149.21

Tesco (TSCO) Director name: Murphy,Ken Amount purchased: 49 @ 276.84p Value: £135.65

Top Director Sells